Antimicrobial and anti-inflammatory activity of five Taxandria fragrans oils in vitro

Microbiology and Immunology

Volumn 52, Issue 11, 2008, Pages 522-530

  Hammer, Katherine A ^a   Carson, Christine F ^a   Dunstan, Janet A ^a   Hale, Jasmine ^a   Lehmann, Heidi ^a   Robinson, Christopher J ^b   Prescott, Susan L ^b   Riley, Thomas V ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b GREENING AUSTRALIA   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Agonis; Myrtaceae; Myrtenol; Terpenes

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ESSENTIAL OIL; ESSENTIAL OIL A; ESSENTIAL OIL B; ESSENTIAL OIL C; ESSENTIAL OIL X; ESSENTIAL OIL Z; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; VEGETABLE OIL;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG INHIBITION; DRUG SENSITIVITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYRTACEAE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; STAPHYLOCOCCUS AUREUS; TAXANDRIA FRAGRANS; YEAST; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; DRUG EFFECT; IMMUNOLOGY; MICROBIOLOGICAL EXAMINATION; MONONUCLEAR CELL;

AGONIS; MYRTACEAE; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYTOKINES; HUMANS; LEUKOCYTES, MONONUCLEAR; MICROBIAL SENSITIVITY TESTS; MYRTACEAE; PLANT OILS; STAPHYLOCOCCUS AUREUS;

EID: 58249092355     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00070.x     Document Type: Article

References (33)

1. Wheeler J.R., Marchant N.G. (2007) A revision of the Western Australian genus Agonis (Myrtaceae) and two new segregate genera Taxandria and Paragonis. Nuytsia 16: 393-433.
2. Wheeler J.R., Marchant N.G., Robinson C.J. (2001) Agonis fragrans (Myrtaceae), a new species from Western Australia. Nuytsia 13: 567-70.
3. Coates D., Atkins K. (2001) Priority setting and the conservation of Western Australia's diverse and highly endemic flora. Biol Conserv 97: 251-63.
4. Myers N., Mittermeier R., Mittermeier C., da Fonseca G., Kent J. (2000) Biodiversity hotspots for conservation priorities. Nature 403: 853-8.
5. Carson C.F., Hammer K.A., Riley T.V. (2006) Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19: 50-62.
6. López P., Sánchez C., Batlle R., Nerin C. (2005) Solid- and vapor-phase antimicrobial activities of six essential oils: susceptibility of selected foodborne bacterial and fungal strains. J Agric Food Chem 53: 6939-46.
7. Porter N., Wilkins A. (1999) Chemical, physical and antimicrobial properties of essential oils of Leptospermum scoparium and Kunzea ericoides. Phytochem 50: 407-15.
8. Wilkinson J.M., Hipwell M., Ryan T., Cavanagh H.M. (2003) Bioactivity of Backhousia citriodora: antibacterial and antifungal activity. J Agric Food Chem 51: 76-81.
9. Brand C., Ferrante A., Prager R.H., Riley T.V., Carson C.F., Finlay-Jones J.J., Hart P.H. (2001) The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res 50: 213-9.
10. Khalil Z., Pearce A.L., Satkunanathan N., Storer E., Finlay-Jones J.J., Hart P.H. (2004) Regulation of wheal and flare by tea tree oil: complementary human and rodent studies. J Invest Dermatol 123: 683-90.
11. Lowe R.F., Russell M.F., Southwell I.A., Robinson C.J., Day J. (2007) Composition of an essential oil from Agonis fragrans J.R. Wheeler et N.G. Marchant. J Essent Oil Res 19: 342-4.
12. Clinical Laboratory Standards Institute. (2006) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard- Seventh Edition. Peninsula Pharmaceuticals, Inc.
13. Clinical Laboratory Standards Institute. (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard - Second Edition. University of Iowa College of Medicine.
14. Carson C.F., Mee B.J., Riley T.V. (2002) Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother 46: 1914-20.
15. Hammer K.A., Carson C.F., Riley T.V. (1996) Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Infect Control 24: 186-9.
16. Prescott S.L., Macaubas C., Holt B.J., Smallacombe T.B., Loh R., Sly P.D., Holt P.G. (1998) Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 160: 4730-7.
17. Macaubas C., Sly P.D., Burton P., Tiller K., Yabuhara A., Holt B.J., Smallacombe T.B., Kendall G., Jenmalm M.C., Holt P.G. (1999) Regulation of T-helper cell responses to inhalant allergen during early childhood. Clin Exp Allergy 29: 1223-31.
18. Upham J.W., Holt B.J., Baron-Hay M.J., Yabuhara A., Hales B.J., Thomas W.R., Loh R.K., O'Keeffe P.T., Palmer L., Le Souef P.N., Sly P.D., Burton P.R., Robinson B.W.S., Holt P.G. (1995) Inhalant allergen-specific T-cell reactivity is detectable in close to 100% of atopic and normal individuals: covert responses are unmasked by serum-free medium. Clin Exp Allergy 25: 634-42.
19. Dunstan J., Mori T., Barden A., Beilin L., Taylor A., Holt P., Prescott S. (2003) Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomised controlled trial. J Allergy Clin Immunol 112: 1178-84.
20. Friedman M., Henika P., Levin C., Mandrell R. (2004) Antibacterial activities of plant essential oils and their components against Escherichia coli O157:H7 and Salmonella enterica in apple juice. J Agric Food Chem 52: 6042-8.
21. Hammer K.A., Carson C.F., Riley T.V. (1999) Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 86: 985-90.
22. Takahashi T., Kokubo R., Sakaino M. (2004) Antimicrobial activities of eucalyptus leaf extracts and flavonoids from Eucalyptus maculata. Lett Appl Microbiol 39: 60-4.
23. Banes-Marshall L., Cawley P., Phillips C.A. (2001) In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. isolates from clinical specimens. Br J Biomed Sci 58: 139-45.
24. Hammer K.A., Carson C.F., Riley T.V. (2003) Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. J Appl Microbiol 95: 853-60.
25. Cox S.D., Mann C.M., Markham J.L. (2001) Interactions between components of the essential oil of Melaleuca alternifolia. J Appl Microbiol 91: 492-7.
26. Burt S. (2004) Essential oils: their antibacterial properties and potential applications in foods - a review. Int J Food Microbiol 94: 223-53.
27. Wills-Karp M. (2004) Interleukin-13 in asthma pathogenesis. Curr Allergy Asthma Rep 4: 123-31.
28. Elenkov I.J., Chrousos G.P. (2002) Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966: 290-303.
29. Vigo E., Cepeda A., Gualillo O., Perez-Fernandez R. (2004) In-vitro anti-inflammatory effect of Eucalyptus globulus and Thymus vulgaris: nitric oxide inhibition in J774A.1 murine macrophages. J Pharm Pharmacol 56: 257-63.
30. Juergens U., Engelen T., Racké K., Stöber M., Gillissen A., Vetter H. (2004) Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. Pulmon Pharmacol Therapeutics 17: 281-7.
31. Bassett I.B., Pannowitz D.L., Barnetson R.St.C. (1990) A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 153: 455-8.
32. Burke B.E., Baillie J.E., Olson R.D. (2004) Essential oil of Australian lemon myrtle (Backhousia citriodora) in the treatment of molluscum contagiosum in children. Biomed Pharmacother 58: 245-7.
33. Shahi S.K., Shukla A.C., Bajaj A.K., Banerjee U., Rimek D., Midgely G., Dikshit A. (2000) Broad spectrum herbal therapy against superficial fungal infections. Skin Pharmacol Appl Skin Physiol 13: 60-4.